This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

JAMES F. WEIR, M.D.; MANDRED W. COMFORT, M.D.

Arch Intern Med. 1933;52(5):685-724.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Shortly after the introduction of cinchophen into the therapeutic armamentarium, patients revealing toxic effects were observed, and their cases were reported in the literature. In 1922, Schroeder¹ reported a series of cases, and urged caution in the use of the drug. In 1923, Worster-Drought² first reported the occurrence of jaundice as a toxic manifestation. The toxic symptoms are of various types: cutaneous, anaphylactoid, gastro-intestinal, cardiac, renal and hepatic. An extensive review of the question of the toxicity of cinchophen is being prepared by our colleague, Dr. Hench.³ In this paper we are concerned only with cases in which there were hepatic manifestations. We have been able to find 98 cases reported in the literature, exclusive of those previously reported from the Mayo Clinic. The latter cases, together with others reported now for the first time, total 19, in 5 of which the results were fatal. This gives . . . [Full Text PDF of this Article]

Author Affiliations
ROCHESTER, MINN.

From the Division of Medicine, the Mayo Clinic.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?